In 2025, the Indiana University School of Medicine made significant advancements toward its strategic goals in medical education, research and Hoosier wellness.
The new Medical Education and Research Building is now open, serving as home base for Indianapolis medical students, all student services and several faculty labs. This flagship building is the culmination of a synergistic vision between IU School of Medicine and IU Health for a world-class facility in downtown Indianapolis that would not only train medical doctors but also create space for innovative biomedical science, ultimately impacting Hoosier health for the better.
Maximizing learner success statewide
Match Day 2025
The IU School of Medicine Class of 2025 matched 341 students with residency training programs throughout the United States. About 43% of these graduates entered primary care residency programs, meeting a crucial need across Indiana and beyond.
LCME reaccreditation
IU School of Medicine has received full accreditation from the Liaison Committee on Medical Education for the maximum eight-year term, through the 2032-33 academic year. This achievement reflects the dedication, collaboration and excellence of the school’s entire statewide community — students, faculty, staff and education partners across all nine campuses.
Bloomington residency expansions
Internal Medicine and Emergency Medicine Residency programs expanded to IU School of Medicine’s Bloomington campus and will welcome their inaugural classes in July 2026. Both are sponsored by the Accreditation Council for Graduate Medical Education (ACGME). The Internal Medicine Residency has a special focus on training in rural and critical access settings.
Accelerating discovery and clinical translation
Mobile lung cancer screening
Indiana’s first mobile lung screening program launched this year. A 40-foot truck with a CT scanner is bringing lifesaving lung screenings directly to Hoosiers across the state. The program is a collaboration between the IU Melvin and Bren Simon Comprehensive Cancer Center and IU Health and is being led by Nasser Hanna, MD.
Entrepreneurial research and commercialization
D. Wade Clapp, MD, has been named the inaugural senior associate dean for entrepreneurial research and commercialization. In this role, he will serve as IU School of Medicine’s scientific lead for the IU Launch Accelerator for Biosciences, known as IU LAB.
Alzheimer’s disease research funding
TREAT-AD, the Alzheimer’s disease drug discovery center at IU School of Medicine, received a five-year, $41.6-million grant renewal from the NIH National Institute on Aging, while a new initiative known as MAP-AD was awarded a five-year, $16.5-million grant to advance precision medicine in Alzheimer’s treatment. Indiana is leading the way nationally as home to one of only two centers in the U.S. dedicated to developing stem cell-based models of the human brain to better understand the underlying causes of Alzheimer’s disease and related dementias.
Improving health and wellness of the people of Indiana and beyond
Tobias-Lechleiter Institute for Clinical Innovation
Indianapolis residents Sarah and John Lechleiter and Deborah and Randall Tobias partnered to make a $20 million gift commitment to IU School of Medicine and IU Health that will establish the Institute of Clinical Innovation. The institute aims to advance healthcare discovery to benefit patients in Indiana and around the world, serving as a hub for groundbreaking disease detection and treatment.
Rural Medical Education Program impact
The Rural Medical Education Program at IU School of Medicine—Terre Haute has produced 177 medical school graduates, most of whom now practice in primary care fields in Indiana’s rural communities. Across the U.S., an estimated 83 million people live in areas that are medically underserved, with 80% of rural America falling into that category. The rural medicine program recruits students from Indiana’s rural communities who are likely to return there to practice.
Komen Tissue Bank donations for breast cancer research
About 400 women answered the call to help cancer researchers by donating their healthy breast tissue during the All-Star Cure collection event on July 12-13, ahead of the WNBA All-Star Game. The event was a partnership between the WNBA All-Star 2025 Host Committee and the Susan G. Komen Tissue Bank, a resource within the Vera Bradley Foundation Center for Breast Cancer Research at the IU Simon Comprehensive Cancer Center. The goal to collect breast tissue from women under age 40 and from women of color was met. It is important to understand the differences in breast tissue among people with different genetic ancestries and how that affects the development of breast cancer.
Welcoming New Leaders
IU School of Medicine named several new leaders in 2025 to advance areas critical to its strategic mission.
- Neil Perdue, PhD, Executive Associate Dean for Strategy and Enterprise Alignment
- Peter Pang, MD, Executive Associate Dean for Clinical Affairs
- Bradley Allen, MD, PhD, Executive Associate Dean for Educational Affairs
- John Turchi, PhD, Chair of the recently merged Department of Biochemistry, Molecular Biology and Pharmacology
- Matthew Feinstein, MD, and Sara Pereira, MD, Cardiovascular Institute co-directors
School leadership transition
In 2026, IU School of Medicine will say farewell to Dean Jay L. Hess, MD, PhD, MHSA, after nearly 13 years of his transformative leadership and dedication to advancing the school’s missions. A nationwide search is being launched for the next dean of the IU School of Medicine.
